Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

ClinicalTrials.gov ID: NCT01289041

Public ClinicalTrials.gov record NCT01289041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma

Study identification

NCT ID
NCT01289041
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

  • BKM120 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Feb 28, 2014
Completion
Feb 28, 2014
Last update posted
May 29, 2019

2011 – 2014

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
St. Joseph's Hospital & Medical Center St Joseph's Phoenix Arizona 85013
Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville Arkansas 72703
Morristown Memorial Hospital MMH Morristown New Jersey 07962
Carolinas HealthCare Systems Blumenthal Cancer Center Charlotte North Carolina 28207
University of Oklahoma Health Sciences Center OU Health Oklahoma City Oklahoma 73104
Sarah Cannon Research Institute SCRI (2) Nashville Tennessee 37203
Texas Oncology, P.A. Austin Bedford Texas 76022
South Texas Oncology and Hematology, PA South Tex Onc San Antonio Texas 78258
Cancer Care Northwest CC Northwest- Spokane South(3) Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01289041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2019 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01289041 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →